These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10970381)

  • 21. Comparability of antimicrobial susceptibility test results from 22 European countries and Israel: an external quality assurance exercise of the European Antimicrobial Resistance Surveillance System (EARSS) in collaboration with the United Kingdom National External Quality Assurance Scheme (UK NEQAS).
    Bronzwaer S; Buchholz U; Courvalin P; Snell J; Cornaglia G; de Neeling A; Aubry-Damon H; Degener J;
    J Antimicrob Chemother; 2002 Dec; 50(6):953-64. PubMed ID: 12461017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of susceptibility testing practices for Streptococcus pneumoniae--United States, February 2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 May; 51(18):392-4. PubMed ID: 12018795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A survey of methods used for antimicrobial susceptibility testing in veterinary diagnostic laboratories in the United States.
    Dargatz DA; Erdman MM; Harris B
    J Vet Diagn Invest; 2017 Sep; 29(5):669-675. PubMed ID: 28599616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance accuracy of antibacterial and antifungal susceptibility test methods: report from the College of American Pathologists Microbiology Surveys Program (2001-2003).
    Pfaller MA; Jones RN;
    Arch Pathol Lab Med; 2006 Jun; 130(6):767-78. PubMed ID: 16740026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial proficiency testing of National Nosocomial Infections Surveillance System hospital laboratories.
    Hageman JC; Fridkin SK; Mohammed JM; Steward CD; Gaynes RP; Tenover FC;
    Infect Control Hosp Epidemiol; 2003 May; 24(5):356-61. PubMed ID: 12785410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro susceptibility test practices with Haemophilus influenzae among College of American Pathologists survey participants in the United States.
    Doern GV; Jones RN
    Diagn Microbiol Infect Dis; 1993 Jul; 17(1):61-5. PubMed ID: 8359008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories.
    Matuschek E; Brown DF; Kahlmeter G
    Clin Microbiol Infect; 2014 Apr; 20(4):O255-66. PubMed ID: 24131428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparisons of the in vitro susceptibility testing results for garenoxacin using six different national methods: report from the garenoxacin international bridging study.
    Jones RN; Gordon KA; Biedenbach DJ
    J Antimicrob Chemother; 2004 Feb; 53(2):258-65. PubMed ID: 14729758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines.
    Gales AC; Reis AO; Jones RN
    J Clin Microbiol; 2001 Jan; 39(1):183-90. PubMed ID: 11136768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proposed MIC quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using seven veterinary antimicrobial agents: ceftiofur, enrofloxacin, florfenicol, penicillin G-novobiocin, pirlimycin, premafloxacin, and spectinomycin.
    Marshall SA; Jones RN; Wanger A; Washington JA; Doern GV; Leber AL; Haugen TH
    J Clin Microbiol; 1996 Aug; 34(8):2027-9. PubMed ID: 8818906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ability of Latin America laboratories to detect antimicrobial resistance patterns: experience of the SENTRY Antimicrobial Surveillance Program (1997-2000).
    Mendes RE; Reis AO; Gales AC; Jones RN; Sader HS
    Braz J Infect Dis; 2003 Oct; 7(5):282-9. PubMed ID: 14552736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility testing practices for Streptococcus pneumoniae: results of a proficiency testing survey of clinical laboratories.
    Edson DC; Glick T; Massey LD
    Diagn Microbiol Infect Dis; 2006 Jul; 55(3):225-30. PubMed ID: 16545934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group.
    Bale MJ; Jones RN
    J Clin Microbiol; 1993 Sep; 31(9):2538-40. PubMed ID: 8408586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a rapid inoculum preparation method for agar disk diffusion susceptibility testing.
    D'Amato RF; Hochstein L
    J Clin Microbiol; 1982 Feb; 15(2):282-5. PubMed ID: 7068824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re-evaluation of quality control guidelines for gatifloxacin and garenoxacin (BMS284756) when susceptibility testing Haemophilus influenzae and Streptococcus pneumoniae.
    Anderegg TR; Biedenbach DJ; Jones RN;
    Diagn Microbiol Infect Dis; 2003 Jun; 46(2):147-50. PubMed ID: 12812719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overview of Changes to the Clinical and Laboratory Standards Institute
    Humphries R; Bobenchik AM; Hindler JA; Schuetz AN
    J Clin Microbiol; 2021 Nov; 59(12):e0021321. PubMed ID: 34550809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interlaboratory variations of fluoroquinolone susceptibility testing. An international study to validate the quality of microbiology results reported during the fleroxacin clinical trials.
    Jones RN; Erwin ME; Hager HL; Hohl PE
    Diagn Microbiol Infect Dis; 1993 Oct; 17(3):225-32. PubMed ID: 8112032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proposed quality control guidelines for National Committee for Clinical Laboratory Standards Susceptibility Tests using the veterinary antimicrobial agent tiamulin.
    Pfaller MA; Jones RN; Walter DH;
    Diagn Microbiol Infect Dis; 2001; 40(1-2):67-70. PubMed ID: 11448566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly reproducible bactericidal activity test results by using a modified National Committee for Clinical Laboratory Standards broth macrodilution technique.
    Hacek DM; Dressel DC; Peterson LR
    J Clin Microbiol; 1999 Jun; 37(6):1881-4. PubMed ID: 10325341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical microbiology laboratories do not always detect resistance of Haemophilus influenzae with disk or tablet diffusion methods. Finnish Study Group for Antimicrobial Resistance (FiRe).
    Manninen R; Huovinen P; Nissinen A
    APMIS; 1998 Apr; 106(4):434-40. PubMed ID: 9637264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.